<p>Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy, share best practices and lessons learned during the drive to get a biopharmaceutical startup to the clinic as quickly as possible.</p>

Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy, share best practices and lessons learned during the drive to get a biopharmaceutical startup to the clinic as quickly as possible.

Special Edition #5: Accelerating Your Biopharma Startup's Path To The Clinic

Life Science Connect Editorial Director, Dan Schell, works with a talented and passionate group of editors. Each week, he sits down with them to discuss their pressing coverage areas, latest travels, and interesting interviews from within the life sciences landscape. His rotating cast of contributors includes Life Science Connect editors Rob Wright, Ed Miseta, Louis Garguilo, Anna Rose Welch, Erin Harris, and Matt Pillar.

Share Special Edition #5: Accelerating Your Biopharma Startup's Path To The Clinic

Sign up to save your podcasts

Special Edition #5: Accelerating Your Biopharma Startup's Path To The Clinic

Special Edition #5: Accelerating Your Biopharma Startup's Path To The Clinic